Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials

This publication has 23 references indexed in Scilit:

• Prevention of Mother-to-Child Transmission of HIV-1 Through Breast-Feeding by Treating Infants Prophylactically With Lamivudine in Dar es Salaam, Tanzania
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
• Diagnosis of HIV-1 Infection in Children Younger Than 18 Months in the United States
  Pediatrics, 2007
• Persistence of K103N‐Containing HIV‐1 Variants after Single‐Dose Nevirapine for Prevention of HIV‐1 Mother‐to‐Child Transmission
  The Journal of Infectious Diseases, 2007
• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
  Published by Wiley ,2007
• Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine
  New England Journal of Medicine, 2007
• Quantitative Analysis of HIV-1 Variants With the K103N Resistance Mutation After Single-Dose Nevirapine in Women With HIV-1 Subtypes A, C, and D
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy
  New England Journal of Medicine, 2004
• Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial
  The Lancet, 2003
• A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1
  The Journal of Infectious Diseases, 2003
• Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial
  The Lancet, 2002